Granix and Memory loss - a phase IV clinical study of FDA data

Summary:

Memory loss is reported as a side effect among people who take Granix (tbo-filgrastim), especially for people who are female, 60+ old, also take Ibrance, and have Metastases to bone.

The phase IV clinical study analyzes which people have Memory loss when taking Granix. It is created by eHealthMe based on reports of 897 people who have side effects when taking Granix from the FDA, and is updated regularly.

What is Granix?

Granix has active ingredients of tbo-filgrastim. eHealthMe is studying from 897 Granix users. Check the latest studies of Granix.

What is Memory loss?

Memory loss is found to be associated with 2,728 drugs and 4,375 conditions by eHealthMe. Check the latest studies of Memory loss.

On Jul, 11, 2026

897 people reported to have side effects when taking Granix.
Among them, 16 people (1.78%) have Memory loss.

Among these 16 people:

What is the gender of people who have Memory loss when taking Granix? *

female: 93.75 %
male: 6.25 %

What is the age of people who have Memory loss when taking Granix? *

What are other drugs people take besides Granix? *

What are other side effects people have besides Memory loss? *

Hair Loss: 10 people, 62.50%
Malaise (a feeling of general discomfort or uneasiness): 10 people, 62.50%
Weakness: 9 people, 56.25%
Headache (pain in head): 9 people, 56.25%
Fatigue (feeling of tiredness): 8 people, 50.00%
Feeling Abnormal: 8 people, 50.00%
Hypermagnesaemia (an electrolyte disturbance in which there is an abnormally elevated level of magnesium in the blood): 7 people, 43.75%
Joint Swelling: 7 people, 43.75%
Joint Pain: 7 people, 43.75%
White Blood Cell Count Decreased: 7 people, 43.75%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 8 people, 50.00%
Breast Cancer Female: 7 people, 43.75%
White Blood Cell Count Decreased: 3 people, 18.75%
Magnesium Deficiency (lack of magnesium): 3 people, 18.75%
Breast Cancer Metastatic: 3 people, 18.75%
Blood Potassium Decreased: 3 people, 18.75%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 12.50%
Neoplasm Malignant (cancer tumour): 1 person, 6.25%
Multiple Myeloma (cancer of the plasma cells): 1 person, 6.25%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Granix and have Memory loss?

- Check whether Memory loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Granix:

Granix (897 reports)

Memory loss treatments and more:

Memory loss (244,444 reports)

Browse all side effects of Granix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Memory loss:

Memory loss (2,728 drugs)

Browse all the conditions that are associated with Memory loss:

Memory loss (4,375 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tbo-filgrastim (the active ingredients of Granix) and Granix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.